US Patent 11390642 Compositions comprising reversibly modified oligonucleotides and uses thereof
Patent 11390642 was granted and assigned to Dicerna Pharmaceuticals on July, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11390642 Compositions comprising reversibly modified oligonucleotides and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
